Azoulay Sandy, Adem Camilo, Pelletier François L E, Barete Stéphane, Francès Camille, Capron Frédérique
Department of Anatomic Pathology, Groupe Hospitalier Pitie Salpetriere, Paris, France.
J Cutan Pathol. 2005 Sep;32(8):561-6. doi: 10.1111/j.0303-6987.2005.00386.x.
Determining the primary origin of skin metastases might be a challenging issue for pathologists, especially when there is no primary history or when this history is unavailable. The poor specificity of morphological appreciation is challenging, emphasizing the need for ancillary studies. We have retrieved 44 cases of skin metastases from our pathology files. Paraffin blocks were collected and homemade tissue arrays were made. We have tried to assess the primary origin based on morphological data alone, and then using 13 antibodies (cytokeratins (CK) 5/6, 7, 19, 20, thyroid transcription factor-1, carcinoembryonic antigen, PS100, tumor-associated glycoprotein 72, BerEP4, estrogen receptor (ER), progesterone receptor (PR), CD10, and E-cadherin). Most metastases in our series were from breast (13) and colorectal cancers (six) as they are the main clinical activity in our hospital. Only 44% of cases were correctly assessed based on the sole morphology, emphasizing the need for ancillary studies. CK 20, ER, and PR were the most helpful markers to determine the primary origin of skin metastases by highlighting colorectal origin and mammary origin, respectively. By far, clinical information and morphological evaluation are more reliable than the use of ancillary techniques, which have to be used in the absence of the former one and the poor differentiation of the latter ones. Azoulay S, Adem C, Le Pelletier F, Barete S, Francès C, Capron F. Skin metastases from unknown origin: role of immunohistochemistry in the evaluation of cutaneous metastases of carcinoma of unknown origin.
对于病理学家而言,确定皮肤转移瘤的原发灶可能是一个具有挑战性的问题,尤其是在没有原发病史或无法获取该病史的情况下。形态学评估的特异性较差,这凸显了辅助研究的必要性。我们从病理档案中检索出44例皮肤转移瘤病例。收集石蜡块并制作自制组织芯片。我们尝试先仅基于形态学数据评估原发灶,然后使用13种抗体(细胞角蛋白(CK)5/6、7、19、20、甲状腺转录因子-1、癌胚抗原、PS100、肿瘤相关糖蛋白72、BerEP4、雌激素受体(ER)、孕激素受体(PR)、CD10和E-钙黏蛋白)进行评估。我们系列中的大多数转移瘤来自乳腺癌(13例)和结直肠癌(6例),因为它们是我院的主要临床病种。仅根据单纯形态学,只有44%的病例得到了正确评估,这凸显了辅助研究的必要性。CK 20、ER和PR是确定皮肤转移瘤原发灶最有用的标志物,分别突出了结直肠来源和乳腺来源。到目前为止,临床信息和形态学评估比使用辅助技术更可靠,辅助技术必须在缺乏前者且后者分化不良的情况下使用。阿祖莱S、阿德姆C、勒佩尔捷F、巴雷特S弗朗塞斯C、卡普龙F。不明来源的皮肤转移瘤:免疫组化在评估不明来源癌皮肤转移中的作用。